Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "gastric wall mechanoreceptor" refers to specialized sensory nerve endings located within the muscular layers of the stomach that detect mechanical changes such as stretch, tension, and distension. These receptors are primarily responsible for sensing physical changes during food intake—such as when the stomach fills—and converting these mechanical stimuli into neural signals that travel via vagal afferents to the brain[3][4]. There are two main conceptual types described in animal models:\n\n1. **In-series tension receptors:** Respond mainly to increases in tension within the stomach wall during distension or contraction against resistance.\n2. **In-parallel elongation receptors:** Respond primarily to elongation/stretching along with muscle fibers[3].\n\nThese sensory mechanisms play crucial roles in regulating satiety signals, coordinating gastric motility patterns like peristalsis and mixing contractions[5], and mediating reflexes that control digestive function. The activation threshold for perception is thought to be related more closely to changes in wall tension than simple volume expansion.\n\nImportantly, "gastric wall mechanoreceptors" do not refer to a single protein or gene product but rather describe a physiological function carried out by various types of nerve endings—primarily those associated with vagal afferent fibers—embedded within different layers of the gastric musculature[4]. As such:\n\n- There is no canonical gene/protein name.\n- No specific abbreviation exists.\n- They are not considered classical drug targets like GPCRs or ion channels.\n\nWhile their dysfunction may contribute indirectly to symptoms seen in some gastrointestinal disorders (e.g., altered visceral sensitivity), they are not currently targeted by any approved drugs nor used as clinical biomarkers.\n\nBecause this entry does not correspond to an individual molecule/receptor with defined structure/function relationships suitable for structured drug discovery databases—and instead describes a broad class based on anatomical/physiological criteria—it should be flagged as incorrect for most structured pharmacological purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric wall mechanoreceptor.